Drug Concentration-Time Profile in the Plasma Following the Dissolution-Type Transdermal Delivery.

Accession number;03A0107690
Title;Drug Concentration-Time Profile in the Plasma Following the Dissolution-Type Transdermal Delivery.
Author; MORI D (Kyushu Inst. Technol., Fukuoka, Jpn) KAWAMATA H (Kyushu Inst. Technol., Fukuoka, Jpn) TOJO K (Kyushu Inst. Technol., Fukuoka, Jpn)
Journal Title;J Chem Eng Jpn
Journal Code:S0629A
ISSN:0021-9592
VOL.36;NO.1;PAGE.45-48(2003)
Figure&Table&Reference;FIG.3, TBL.1, REF.10
Pub. Country;Japan
Language;English
Abstract;In medical treatment, a constant plasma concentration for an extended period of time is preferable for some diseases, while pulsatile delivery or delayed delivery is also required to avoid the tolerance and set a delayed time for medication. The dissolution-type TTS is expected to achieve pulsatile delivery. In this work, a mathematical model was proposed for the prediction of the plasma concentration-time profile following the application of the dissolution-type TTS. In vivo animal data was compared with the simulated profile together with the model parameters determined independently. The calculated concentration-time profile well agreed with the in vivo animal data. (author abst.)
FULLTEXT